» Articles » PMID: 22271752

Classification of Heart Failure in the Atherosclerosis Risk in Communities (ARIC) Study: a Comparison of Diagnostic Criteria

Overview
Journal Circ Heart Fail
Date 2012 Jan 25
PMID 22271752
Citations 240
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Population-based research on heart failure (HF) is hindered by lack of consensus on diagnostic criteria. Framingham (FRM), National Health and Nutrition Examination Survey (NHANES), Modified Boston (MBS), Gothenburg (GTH), and International Classification of Disease, 9th Revision, Clinical Modification (ICD-9-CM) code criteria, do not differentiate acute decompensated heart failure (ADHF) from chronic stable HF. We developed a new classification protocol for identifying ADHF in the Atherosclerosis Risk in Communities (ARIC) Study and compared it with these other schemes.

Methods And Results: A sample of 1180 hospitalizations with a patient address in 4 study communities and eligible discharge codes were selected. After assessing whether the chart contained evidence of possible HF signs, 705 were fully abstracted. Two independent reviewers classified each case as ADHF, chronic stable HF, or no HF, using ARIC classification guidelines. Fifty-nine percent of cases met ARIC criteria for ADHF and 13.9% and 27.1% were classified as chronic stable HF or no HF, respectively. Among events classified as HF by FRM criteria, 68.4% were validated as ADHF, 9.6% as chronic stable HF, and 21.9% as no HF. However, 92.5% of hospitalizations with a primary ICD-9-CM 428 "heart failure" code were validated as ADHF. Sensitivities of comparison criteria to classify ADHF ranged from 38-95%, positive predictive values from 62-92%, and specificities from 19-96%.

Conclusions: Although comparison criteria for classifying HF were moderately sensitive in identifying ADHF, specificity varied when applied to a randomly selected set of suspected HF hospitalizations in the community.

Citing Articles

Does Adiponectin Inform Cardiovascular Risk in Older Adults?: The ARIC Study.

Abushamat L, Jia X, Xu L, Cheng C, Ndumele C, Sun C JACC Adv. 2025; 4(3):101625.

PMID: 39983616 PMC: 11891717. DOI: 10.1016/j.jacadv.2025.101625.


The Relationship of Duffy Gene Polymorphism with High-Sensitivity C-Reactive Protein, Mortality, and Cardiovascular Outcomes in Black Individuals.

Ha E, Haessler J, Taylor K, Tuftin B, Briggs M, Parikh M Genes (Basel). 2024; 15(11).

PMID: 39596582 PMC: 11594091. DOI: 10.3390/genes15111382.


Impact of pulse pressure variability evaluated by visit-to-visit on heart failure events in patients with hypertension: insights from the SPRINT trial.

Ma H, Wang M, Qin C, Mandizadza O, Wu L, Cong R Eur J Med Res. 2024; 29(1):559.

PMID: 39582008 PMC: 11587737. DOI: 10.1186/s40001-024-02164-0.


Multimorbidity Trajectories From Early to Middle Adulthood and Physical Activity.

Dooley E, Bowling C, Hornikel B, Chen B, Badon S, Lewis C Am J Prev Med. 2024; 68(3):611-615.

PMID: 39577673 PMC: 11830553. DOI: 10.1016/j.amepre.2024.11.003.


Prediabetes is associated with elevated risk of clinical outcomes even without progression to diabetes.

Rooney M, Wallace A, Echouffo Tcheugui J, Fang M, Hu J, Lutsey P Diabetologia. 2024; 68(2):357-366.

PMID: 39531040 PMC: 11732724. DOI: 10.1007/s00125-024-06315-0.


References
1.
Kim J, Jacobs Jr D, Luepker R, Shahar E, Margolis K, Becker M . Prognostic value of a novel classification scheme for heart failure: the Minnesota Heart Failure Criteria. Am J Epidemiol. 2006; 164(2):184-93. DOI: 10.1093/aje/kwj168. View

2.
Levy D, Kenchaiah S, Larson M, Benjamin E, Kupka M, Ho K . Long-term trends in the incidence of and survival with heart failure. N Engl J Med. 2002; 347(18):1397-402. DOI: 10.1056/NEJMoa020265. View

3.
Krumholz H, Merrill A, Schone E, Schreiner G, Chen J, Bradley E . Patterns of hospital performance in acute myocardial infarction and heart failure 30-day mortality and readmission. Circ Cardiovasc Qual Outcomes. 2009; 2(5):407-13. DOI: 10.1161/CIRCOUTCOMES.109.883256. View

4.
Allen L . Use of multiple biomarkers in heart failure. Curr Cardiol Rep. 2010; 12(3):230-6. DOI: 10.1007/s11886-010-0109-6. View

5.
Dieplinger B, Gegenhuber A, Haltmayer M, Mueller T . Evaluation of novel biomarkers for the diagnosis of acute destabilised heart failure in patients with shortness of breath. Heart. 2009; 95(18):1508-13. DOI: 10.1136/hrt.2009.170696. View